Adrenomedullin in cultured human retinal pigment epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 7, 2000, Pages 1962-1970

  Udono, Tetsuo ^a   Takahashi, Kazuhiro ^a   Nakayama, Masaharu ^a   Murakami, Osamu ^a   Durlu, Yusuf K ^a   Tamai, Makoto ^a   Sbibabara, Shigeki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; BASIC FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 1BETA; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY;

ADRENOMEDULLIN; BLOTTING, NORTHERN; CELL DIVISION; CELLS, CULTURED; CHROMATOGRAPHY, GEL; CYTOKINES; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; HUMANS; PEPTIDES; PIGMENT EPITHELIUM OF EYE; RADIOIMMUNOASSAY; RNA, MESSENGER; TRETINOIN; VASODILATOR AGENTS;

EID: 0034049970     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Kitamura K, Kangawa K, Kawamoto M, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993;192:553-560.
2. Ichiki Y, Kitamura K, Kangawa K, et al. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 1994;338:6-10.
3. Sugo S, Minamino N, Kangawa K, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun. 1994;201:1160-1166.
4. Sugo S, Minamino N, Shoji H, et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-alpha. Biochem Biophys Res Commun. 1994;203:719-726.
5. Satoh F, Takahashi K, Murakami O, et al. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metab. 1995;80:1750-1752.
6. Satoh F, Takahashi K, Murakami O, et al. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci Lett. 1996;203:207-210.
7. Takahashi K, Satoh F, Sone M, et al. Expression of adrenomedullin mRNA in the human brain and pituitary. Peptides. 1997;18:1051-1053.
8. Sone M, Takahashi K, Satoh F, et al. Specific adrenomedullin binding sites in the human brain. Peptides. 1997;18:1125-1129.
9. Owji AA, Smith DM, Coppock HA, et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 1995;136:2127-2134.
10. Withers DJ, Coppock HA, Seufferlein T, et al. Adrenomedullin stimulates DNA synthesis and cell proliferation via elevation of cAMP in Swiss 3T3 cells. FEBS Lett. 1996;378:83-87.
11. Kapas S, Brown DW, Farthing PM, Hagi-Pavli E. Adrenomedullin has mitogenic effects on human oral keratinocytes: involvement of cyclic AMP. FEBS Lett. 1997;418:287-290.
12. Segawa K, Minami K, Sata T, Kuroiwa A, Shigematsu A. Inhibitory effect of adrenomedullin on rat mesangial cell mitogenesis. Nephron. 1996;74:577-579.
13. Horio T, Kohno M, Kano H, et al. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res. 1995;77:660-664.
14. Kano H, Kohno M, Yasunari K, et al. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens. 1996;14:209-213.
15. Samson WK. Proadrenomedullin-derived peptides. Front Neuroendocrinol 1998;19:100-127.
16. Takahashi K, Satoh F, Hara E, et al. Production and secretion of adrenomedullin by cultured choroid plexus carcinoma cells. J Neurochem. 1997;68:726-731.
17. Takahashi K, Satoh F, Hara E, et al. Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production. Peptides. 1997;18:1117-1124.
18. Cunha-Vaz J. The blood-ocular barriers. Surv Opbthalmol. 1979; 23:279-296.
19. Zhao S, Rizzolo LJ, Barnstable CJ. Differentiation and transdiffer entiation of the retinal pigment epithelium. Int Rev Cytol. 1997; 171:225-266.
20. Ryan SJ. The pathophysiology of proliferative vitreoretinopathy in its management. Am J Ophthalmol. 1985;100:188-193.
21. Udono T, Takahashi K, Takano S, Shibahara S, Tamai M. Elevated adrenomedullin levels in the vitreous of patients with proliferative vitreoretinopathy. Am J Ophthalmol. 1999;128:765-767.
22. Choudhury P, Chen W, Hunt RC. Production of platelet-derived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial cells leads to contraction of collagen gels. Invest Ophthalmol Vis Sci. 1997;38:824-833.
23. Jaffe GJ, Van Le L, Valea F, et al. Expression of interleukin-1 alpha, interleukin-1 beta, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp Eye Res. 1992;55:325-335.
24. Planck SR, Huang XN, Robertson JE, Rosenbaum JT. Retinal pigment epithelial cells produce interleukin-1 beta and granulocyte-macrophage colony-stimulating factor in response to interleukin-1 alpha. Curr Eye Res. 1993;12:205-212.
25. Benson MT, Shepherd L, Rees R C, Rennie IG. Production of interleukin-6 by human retinal pigment epithelium in vitro and its regulation by other cytokines. Curr Eye Res. 1992;11:173-179.
26. Einer VM, Stricter RM, Einer SG, et al. Neutrophil chemotactic factor (IL-8) gene expression by cytokine- treated retinal pigment epithelial cells. Am J Pathol. 1990;136:745-750.
27. Tanihara H, Yoshida M, Yoshimura N. Tumor necrosis factor-alpha gene is expressed in stimulated retinal pigment epithelial cells in culture. Biocbem Biophys Res Commun. 1992;187:1029-1034.
28. Tanihara H, Yoshida M, Matsumoto M, Yoshimura N. Identification of transforming growth factor-beta expressed in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1993; 34:413-419.
29. Takagi H, Yoshimura N, Tanihara H, Honda Y. Insulin-like growth factor-related genes, receptors, and binding proteins in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1994;35:916-923.
30. Shima DT, Adamis AP, Ferrara N, et al. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med. 1995;1:182-193.
31. Montuenga LM, Martinez A, Miller MJ, Unsworth EJ, Cuttitta F. Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action. Endocrinology. 1997;138:440-451.
32. Limb GA, Little BC, Meager A, et al. Cytokines in proliferative vitreoretinopathy. Eye. 1991;5:686-693.
33. Limb GA, Alam A, Barley O, et al. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res. 1994;13:791-798.
34. Osusky R, Tao L, Ryan SJ. Interleukin 1 in experimental proliferative vitreoretinopathy. Ophthalmologica. 1997;211:49-52.
35. Kon CH, Occleston NL, Aylward GW, Khaw PT. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci. 1999;40:705-712.
36. Kitamura K, Kato J, Kawamoto M, et al. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem Biophys Res Commun. 1998; 244:551-555.
37. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res. 1996;62:155-169.
38. Davis AA, Bernstein PS, Bok D, et al. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture. Invest Ophthalmol Vis Sci. 1995;36:955-964.
39. Durlu YK, Tamai M. Transplantation of retinal pigment epithelium using viable cryopreserved cells. Cell Transplant. 1997;6:149-162.
40. Totsune K, Mackenzie HS, Totsune H, et al. Upregulation of atrial natriuretic peptide gene expression in remnant kidney of rats with reduced renal mass. J Am Soc Nephrol. 1998;9:1613-1619.
41. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
42. Kitamura K, Sakata J, Kangawa K, et al. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun. 1993;194:720-725.
43. Glaser BM, Lemor M. Pathobiology of Proliferative Vitreoretinopatby. Vol. 3. St. Louis: Mosby, 1994:2249-2263.
44. Newsome DA, Rodrigues MM, Machemer R. Human massive periretinal proliferation: in vitro characteristics of cellular components. Arch Ophthalmol. 1981;99:873-880.
45. Martinez A, Miller MJ, Unsworth EJ, Siegfried JM, Cuttitta F. Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology. 1995;136:4099-4105.
46. Kubo A, Minamino N, Isumi Y, et al. Production of adrenomedullin in macrophage cell line and peritoneal macrophage, J Biol Chem. 1998;273:16730-16738.
47. Nakayama M, Takahashi K, Murakami O, et al. Production and secretion of adrenomedullin in cultured human alveolar macrophages. Peptides. 1999;20:1123-1125.
48. Nakayama M, Takahashi K, Murakami O, et al. Adrenomedullin in monocytes and macrophages: possible involvement of macrophage-derived adrenomedullin in atherogenesis. Clin Sci. 1999;97: 247-251.
49. Isumi Y, Minamino N, Katafuchi T, et al. Adrenomedullin production in fibroblasts: its possible function as a growth regulator of Swiss 3T3 cells. Endocrinology. 1998;139:2552-2563.
50. Takahashi K, Nakayama M, Totsune K, et al. Increased secretion of adrenomedullin from cultured human astrocytes by cytokines. J Neurochem. 2000;74:99-103.
51. Chini EN, Choi E, Grande JP, Burnett J C, Dousa TP. Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem Biophys Res Commun. 1995;215:868-873.
52. Nakayama M, Takahashi K, Murakami O, Shirato K, Shibahara S. Induction of adrenomedullin by hypoxia and cobalt chloride in human colorectal carcinoma cells. Biochem Biophys Res Commun. 1998;243:514-517.
53. Takahashi K, Satoh F, Sone M, et al. Expression of adrenomedullin mRNA in adrenocortical tumors and secretion of adrenomedullin by cultured adrenocortical carcinoma cells. Peptides. 1998;19: 1719-1724.
54. McLatchie LM, Fraser NJ, Main MJ, et al. RAMPs regulate the transport and ligand specificity of the calcitonin- receptor-like receptor. Nature. 1998;393:333-339.
55. Sugo S, Minamino N, Shoji H, Kangawa K, Matsuo H. Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett. 1995;369:311-314.
56. Isumi Y, Shoji H, Sugo S, et al. Regulation of adrenomedullin production in rat endothelial cells. Endocrinology. 1998;139:838-846.
57. Campochiaro PA, Hackett SF, Conway BP. Retinoic acid promotes density-dependent growth arrest in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1991;32:65-72.
58. Immonen I, Siren V, Stephens RW, Liesto K, Vaheri A. Retinoids increase urokinase-type plasminogen activator production by human retinal pigment epithelial cells in culture. Invest Ophthalmol Vis Sci. 1993;34:2062-2067.
59. Oka MS, Landers RA, Bridges CD. A serum-free denned medium for retinal pigment epithelial cells. Exp Cell Res. 1984;154:537-547.
60. Yasunari T, Yanagihara N, Komatsu T, et al. Effect of retinoic acid on proliferation and polyamine metabolism in cultured bovine retinal pigment epithelial cells. Ophthalmic Res. 1999;31:24-32.